AGEN

SEC source: 0001745285-20-000036 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,876

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 9, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $4.35 is the closing price of our Common Stock on October 9, 2020, the payroll date for the pay period ending October 9, 2020.

SEC source: 0001745285-20-000037 · primary_doc.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-10-08

F1 · derivative.exercise_date: Stock Option awarded in connection with Ms. Hirsch's appointment to the Board of Directors in accordance with the Agenus Inc. 2019 Equity Incentive Plan and non-employee director compensation program. Stock option vests in three equal annual installments on each of October 8, 2021, 2022 and 2023 (provided Ms. Hirsch maintains a service relationship with the company through each such vesting date).

SEC source: 0001745285-20-000035 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,282.555

Underlying: Common Stock · 6,464.583 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.964 per Deferred Stock Unit acquired on October 1, 2020. The price of each Deferred Stock Unit acquired prior to October 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquire pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to be a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to be a director of the Company.

SEC source: 0001745285-20-000034 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,384.675

Underlying: Common Stock · 5,360.874 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.964 per Deferred Stock Unit acquired on October 1, 2020. The price of each Deferred Stock Unit acquired prior to October 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-20-000033 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,778.941

Underlying: Common Stock · 2,049.746 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.964 per Deferred Stock Unit acquired on October 1, 2020. The price of each Deferred Stock Unit acquired prior to October 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-20-000032 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,479

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending September 25, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $4.02 is the closing price of our Common Stock on September 25, 2020, the payroll date for the pay period ending September 25, 2020.

SEC source: 0001745285-20-000031 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,803

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending September 11, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $4.99 is the closing price of our Common Stock on September 11, 2020, the payroll date for the pay period ending September 11, 2020.

SEC source: 0001745285-20-000030 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,841

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending August 28, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $4.28 is the closing price of our Common Stock on August 28, 2020, the payroll date for the pay period ending August 28, 2020.

SEC source: 0000899243-20-023658 · doc4.xml · derivative · entry 2

CLARK PAUL N · CIK 0001222248 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,786

Underlying: Common Stock · 11,786 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted Stock Unit granted in connection with Mr. Clark's appointment to the Executive Committee of the Board in accordance with the 2019 Plan. The award vests in full on August 27, 2021 (provided Mr. Clark maintains a service relationship with the company through each such vesting date).

F2 · derivative.expiration_date: Restricted Stock Unit granted in connection with Mr. Clark's appointment to the Executive Committee of the Board in accordance with the 2019 Plan. The award vests in full on August 27, 2021 (provided Mr. Clark maintains a service relationship with the company through each such vesting date).

SEC source: 0000899243-20-023658 · doc4.xml · derivative · entry 1

CLARK PAUL N · CIK 0001222248 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2030-08-27

F1 · derivative.exercise_date: Stock Option awarded in connection with Mr. Clark's appointment to the Board of Directors (the "Board") in accordance with the Agenus Inc. 2019 Equity Incentive Plan (the "2019 Plan") and non-employee director compensation program. Stock option vests in three equal annual installments on each of August 27, 2021, 2022 and 2023 (provided Mr. Clark maintains a service relationship with the company through each such vesting date).

SEC source: 0001745285-20-000029 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 322,389

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending August 14, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $3.71 is the closing price of our Common Stock on August 14, 2020, the payroll date for the pay period ending August 14, 2020.

SEC source: 0001745285-20-000028 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,405

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending July 31, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $3.04 is the closing price of our Common Stock on July 31, 2020, the payroll date for the pay period ending July 31, 2020.

SEC source: 0001745285-20-000027 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,544

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending July 17, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $3.60 is the closing price of our Common Stock on July 17, 2020, the payroll date for the pay period ending July 17, 2020.

SEC source: 0001745285-20-000026 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,439

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending July 3, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $4.02 is the closing price of our Common Stock on July 2, 2020, the payroll date for the pay period ending July 3, 2020.

SEC source: 0001745285-20-000025 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,729.195

Underlying: Common Stock · 2,662.826 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.051 per Deferred Stock Unit acquired on July 1, 2020. The price of each Deferred Stock Unit acquired prior to July 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-20-000024 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,817.972

Underlying: Common Stock · 8,398.143 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.051 per Deferred Stock Unit acquired on July 1, 2020. The price of each Deferred Stock Unit acquired prior to July 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-20-000023 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,023.801

Underlying: Common Stock · 6,964.314 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.051 per Deferred Stock Unit acquired on July 1, 2020. The price of each Deferred Stock Unit acquired prior to July 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0001745285-20-000018 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 305,763

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 19, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $3.83 is the closing price of our Common Stock on June 19, 2020, the payroll date for the pay period ending June 19, 2020.

SEC source: 0001745285-20-000021 · primary_doc.xml · derivative · entry 2

Jeynes-Ellis Allison M · CIK 0001758521 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,338 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.exercise_date: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.expiration_date: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000021 · primary_doc.xml · nonDerivative · entry 1

Jeynes-Ellis Allison M · CIK 0001758521 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,323

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Ms. Jeynes-Ellis was granted 20,338 Restricted Stock Units as part of her annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Ms. Jeynes-Ellis was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000019 · primary_doc.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,118 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.exercise_date: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.expiration_date: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000019 · primary_doc.xml · nonDerivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Mr. Corvese was granted 27,118 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Corvese was issued the underlying 27,118 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000022 · primary_doc.xml · derivative · entry 2

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,338 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.exercise_date: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.expiration_date: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000022 · primary_doc.xml · nonDerivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,876

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000020 · primary_doc.xml · derivative · entry 2

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,338 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On June 19, 2019, Mr. Wiinberg was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wiinberg was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · shares: On June 19, 2019, Mr. Wiinberg was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wiinberg was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Mr. Wiinberg was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wiinberg was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.exercise_date: On June 19, 2019, Mr. Wiinberg was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wiinberg was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · derivative.expiration_date: On June 19, 2019, Mr. Wiinberg was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wiinberg was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001745285-20-000020 · primary_doc.xml · nonDerivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,210

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 19, 2019, Mr. Wiinberg was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wiinberg was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

F1 · price: On June 19, 2019, Mr. Wiinberg was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wiinberg was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan.

SEC source: 0001104659-20-074735 · a4.xml · nonDerivative · entry 2

INCYTE CORP · CIK 0000879169 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,972,968

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.550 to $3.710, inclusive.

SEC source: 0001745285-20-000017 · primary_doc.xml · derivative · entry 2

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2030-06-16

F3 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on June 16, 2021.

SEC source: 0001745285-20-000017 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,191

Underlying: Common Stock · 16,853 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 16, 2021.

F1 · derivative.expiration_date: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 16, 2021.

F2 · balance_after: Includes 20,338 Restricted Stock Units that are scheduled to vest on June 19, 2020.

SEC source: 0001745285-20-000016 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2030-06-16

F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on June 16, 2021.

SEC source: 0001745285-20-000014 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,191

Underlying: Common Stock · 16,853 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award fully vests on June 16, 2021.

F1 · derivative.expiration_date: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award fully vests on June 16, 2021.

F2 · balance_after: Includes 20,338 Restricted Stock Units that are scheduled to vest on June 19, 2020.

SEC source: 0001745285-20-000015 · primary_doc.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2030-06-16

F3 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on June 16, 2021.

SEC source: 0001745285-20-000015 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,589

Underlying: Common Stock · 22,471 shares

Expires not disclosed

F1 · derivative.exercise_price: (1) Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021.

F1 · derivative.expiration_date: (1) Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021.

F2 · balance_after: Includes 27,118 Restricted Stock Units that are scheduled to vest on June 19, 2020.

SEC source: 0001745285-20-000013 · primary_doc.xml · derivative · entry 1

Jeynes-Ellis Allison M · CIK 0001758521 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,191

Underlying: Common Stock · 16,853 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021.

F1 · derivative.expiration_date: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021.

F2 · balance_after: Includes 20,338 Restricted Stock Unit that are scheduled to vest on June 19, 2020.

SEC source: 0001104659-20-074735 · a4.xml · nonDerivative · entry 1

INCYTE CORP · CIK 0000879169 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,114,888

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.650 to $3.700, inclusive. The reporting person undertakes to provide to Agenus Inc., any security holder of Agenus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

SEC source: 0001104659-20-073512 · tm2022693-2_4.xml · nonDerivative · entry 3

INCYTE CORP · CIK 0000879169 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,186,968

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.500 to $3.635, inclusive.

SEC source: 0001745285-20-000011 · primary_doc.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,333

Underlying: Common Stock · 58,333 shares

Expires 2030-06-15

F1 · derivative.exercise_date: Option was granted on June 15, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Option vests on June 15, 2021; provided, however, that the unvested portion of such option shall vest in full upon Dr. Armen's death, disability or retirement.

SEC source: 0001745285-20-000012 · primary_doc.xml · derivative · entry 1

KLASKIN CHRISTINE M · CIK 0001288123 · PFO and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2030-06-15

F1 · derivative.exercise_date: Option was granted on June 15, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Option vests in full on June 15, 2021.

SEC source: 0001745285-20-000010 · primary_doc.xml · derivative · entry 1

Buell Jennifer · CIK 0001711184 · COO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2030-06-15

F1 · derivative.exercise_date: Option was granted on June 15, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Option vests in full on June 15, 2021.

SEC source: 0001104659-20-073512 · tm2022693-2_4.xml · nonDerivative · entry 2

INCYTE CORP · CIK 0000879169 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,570,993

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.500 to $3.650, inclusive.

SEC source: 0001104659-20-073512 · tm2022693-2_4.xml · nonDerivative · entry 1

INCYTE CORP · CIK 0000879169 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,580,093

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.650 to $3.920, inclusive. The reporting person undertakes to provide to Agenus Inc., any security holder of Agenus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.

SEC source: 0001745285-20-000009 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,904

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 5, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $3.85 is the closing price of our Common Stock on June 5, 2020, the payroll date for the pay period ending June 5, 2020.

SEC source: 0001745285-20-000008 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,066

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 22, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $2.50 is the closing price of our Common Stock on May 22, 2020, the payroll date for the pay period ending May 22, 2020.

SEC source: 0001745285-20-000007 · primary_doc.xml · nonDerivative · entry 3

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,155

F3 · kind: Represents deposit into the Garo Armen 2020 2 Year AG GRAT.

SEC source: 0001745285-20-000007 · primary_doc.xml · nonDerivative · entry 2

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 892,155

F2 · kind: Represents deposit into the Garo Armen 2018 2 Year AG GRAT.

SEC source: 0001745285-20-000007 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,051,155

F1 · kind: Represents a distribution from the Garo Armen 2018 2 Year AG GRAT.

SEC source: 0001745285-20-000006 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 892,155

F1 · security: As previously reported in Current Report on Form 8-K with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary in being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 8, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $2.53 is the closing price of our Common Stock on May 8, 2020, the payroll date for the pay period ending May 8, 2020.

SEC source: 0001745285-20-000005 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,112,282

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending April 24, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $2.79 is the closing price of our Common Stock on April 24, 2020, the payroll date for the pay period ending April 24, 2020.

SEC source: 0001745285-20-000004 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,106,986

F1 · security: As previously reported in Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2020, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the balance of 2020. The amount reported herein represents the amount of Dr. Armen's salary for the period ending April 10, 2020. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $2.50 is the closing price of our Common Stock on April 9, 2020, such amount represents the fair market value of our Common Stock on the payroll date for the pay period ending April 10, 2020.

SEC source: 0001745285-20-000003 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,066.369

Underlying: Common Stock · 2,539.446 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $3.200 per Deferred Stock Unit acquired on April 1, 2020. The price of each Deferred Stock Unit acquired prior to April 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.